![Wanted: Suspect for Assault in the 9th District [VIDEO]](https://thephillypi.com/wp-content/uploads/2026/09/Wanted-Suspect-for-Assault-in-the-9th-District-VIDEO-330x220.jpg)
TCGX Acquisition Corp. II (TCXB), a stock-only special purpose acquisition company (SPAC), made a strong debut on the NASDAQ on Friday, October 16, 2026. Opening at $11.20, the Palo Alto-based blank-check company gained 12 percent—or $1.20—from its initial public offering price of $10.00. The offering, which priced the previous night, successfully raised $100 million through the sale of 10 million shares, with Guggenheim Securities serving as the sole book-runner.
Led by CEO Dr. Chen Yu and CFO Craig Skaling of biotech investment firm TCGX, the newly public company intends to focus its search for an acquisition target on the life sciences and medical technology sectors. According to the prospectus, the SPAC may pursue opportunities across Asia, including Hong Kong and the People’s Republic of China. Cayman Islands-incorporated TCGX Acquisition II joins a busy market, representing the 156th SPAC to go public year-to-date.
